Coriell Institute for Medical Research Selects Affymetrix (Santa Clara, California) DMET Plus Product for National Personalized Medicine Project

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (Nasdaq:AFFX) today announced that the Coriell Personalized Medicine Collaborative (CPMC), part of the Coriell Institute for Medical Research, has selected its new DMET Plus Product for a national project to identify biologically relevant markers for drug response. Since the DMET Plus Product was launched last November, five additional organizations have adopted it to support studies investigating the relationship between genes and drug metabolism and 18 are scheduled to be trained.